Immunosuppression therapy for pediatric heart transplantation

Current Treatment Options in Cardiovascular Medicine

Volumn 12, Issue 5, 2010, Pages 489-502

  Irving, Claire A ^b   Webber, Steven A ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTACID AGENT; ANTIFUNGAL AGENT; AZATHIOPRINE; BARBITURIC ACID DERIVATIVE; BASILIXIMAB; BORTEZOMIB; CALCINEURIN INHIBITOR; COLESTYRAMINE; CORTICOSTEROID; CYCLOSPORIN A; CYTOCHROME P450 INHIBITOR; DACLIZUMAB; GANCICLOVIR; IMMUNOGLOBULIN; INTERLEUKIN 2 RECEPTOR ANTIBODY; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; METHOXSALEN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHENYTOIN; POLYCLONAL ANTIBODY; PREDNISONE; RAPAMYCIN; RIFAMPICIN; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY; UNINDEXED DRUG;

ABDOMINAL PAIN; ACNE; ACUTE GRAFT REJECTION; ADJUVANT THERAPY; ADRENAL SUPPRESSION; ADULT RESPIRATORY DISTRESS SYNDROME; ANAPHYLAXIS; ANEMIA; ANGIONEUROTIC EDEMA; ANOREXIA; ANTIBODY MEDIATED REJECTION; ARTHRALGIA; AVASCULAR NECROSIS; BONE MARROW SUPPRESSION; BRAIN DISEASE; BRAIN PSEUDOTUMOR; BRONCHOSPASM; CARDIAC GRAFT REJECTION; CATARACT; CHILD CARE; CHILL; CLINICAL TRIAL; CONTINUOUS INFUSION; DIABETES MELLITUS; DIARRHEA; DRUG ANTAGONISM; DRUG COST; DRUG DOSAGE FORM COMPARISON; DRUG ERUPTION; DRUG FATALITY; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG POTENTIATION; DYSPNEA; EDEMA; FAILURE TO THRIVE; FEVER; GASTROINTESTINAL DISEASE; GASTROINTESTINAL INTOLERANCE; GASTROINTESTINAL SYMPTOM; GINGIVA HYPERTROPHY; GLAUCOMA; GRAFT REJECTION; GROWTH DISORDER; HEART FAILURE; HEART TRANSPLANTATION; HIRSUTISM; HUMAN; HYPERKALEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPOMAGNESEMIA; HYPOTENSION; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL PNEUMONIA; LEUKOPENIA; LIVER TOXICITY; LYMPH NODE IRRADIATION; MOOD CHANGE; MOUTH ULCER; MYALGIA; MYOPATHY; NAUSEA; NEPHROTOXICITY; OSTEOPOROSIS; OUTCOME ASSESSMENT; PANCREATITIS; PARESTHESIA; PERIPHERAL NEUROPATHY; PLASMAPHERESIS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PUVA; REVIEW; SEIZURE; SERUM SICKNESS; SIDE EFFECT; SINGLE DRUG DOSE; STOMACH ULCER; THROMBOCYTOPENIA; TREMOR; UNSPECIFIED SIDE EFFECT; VOMITING; WEIGHT GAIN; WOUND HEALING;

EID: 77956262975     PISSN: 10928464     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11936-010-0085-6     Document Type: Review

References (49)

1. R Kirk LB Edwards P Aurora, et al. 2009 Registry of the International Society for Heart and Lung Transplantation: twelfth official pediatric heart transplantation report-2009 J Heart Lung Transplant 28 993 1006 10.1016/j.healun.2009.08.008 19782282 This annual report of the ISHLT registry demonstrates important changes in trends in immunosuppression over the past decade.
2. JG Gossett CE Canter J Zheng, et al. 2010 Decline in rejection in the first year after pediatric cardiac transplantation: a multi-institutional study J Heart Lung Transplant 29 625 632 10.1016/j.healun.2009.12.009 20207171 This recent analysis of rejection events from the Pediatric Heart Transplant Study makes the important observation that although rejection frequency has fallen, deaths from rejection and rejection with hemodynamic compromise have not decreased.
3. D Schmauss M Weis 2008 Cardiac allograft vasculopathy: recent developments Circulation 117 2131 2141 10.1161/CIRCULATIONAHA.107.711911 18427143
4. MA Dew AD Dabbs L Myakovsky, et al. 2009 Meta-analysis of medical regimen adherence outcomes in pediatric solid organ transplantation Transplantation 88 736 746 10.1097/TP.0b013e3181b2a0e0 19741474
5. LM Russo SA Webber 2004 Pediatric heart transplantation: immunosuppression and its complications Curr Opin Cardiol 19 104 109 10.1097/00001573-200403000-00006 15075734
6. SC Reddy K Laughlin SA Webber 2003 Immunosuppression in Pediatric Heart Transplantation: 2003 and Beyond Curr Treat Options Cardiovasc Med 5 417 428 10.1007/s11936-003-0048-2 12941210
7. NE Lobach SM Pollock-BarZiv LJ West AI Dipchand 2005 Sirolimus immunosuppression in pediatric heart transplant recipients: a single-center experience J Heart Lung Transplant 24 184 189 10.1016/j.healun.2004.11.005 15701435
8. MM Sarwal 2008 Out with the old, in with the new: immunosuppression minimization in children Curr Opin Organ Transplant 13 513 521 10.1097/MOT.0b013e328310b0e0 19060535
9. J Patel JA Kobashigawa 2008 Minimization of immunosuppression Transplant Immunol 20 48 54 10.1016/j.trim.2008.10.001 1:CAS:528:DC%2BD1cXhtlylu7fK
10. TP Singh C Faber ED Blume, et al. 2010 Safety and early outcomes using a corticosteroid-avoidance immunosuppression protocol in pediatric heart transplant recipients J Heart Lung Transplant 29 517 522 10.1016/j.healun.2009. 11.601 20061164 This study from two centers demonstrates that low rejection rates can be achieved with steroid avoidance using tacrolimus and MMF maintenance immunosuppression combined with induction therapy with thymoglobulin.
11. J Simmonds C Dewar H Dawkins, et al. 2009 Tacrolimus in pediatric heart transplantation: ameliorated side effects in the steroid-free, statin era Clin Transplant 23 415 419 10.1111/j.1399-0012.2008.00934.x 19537303
12. P Uber M Mehra 2007 Induction therapy in heart transplantation: is there a role? J Heart Lung Transplant 26 205 209 10.1016/j.healun.2007.01.002 17346621
13. CR Ensor WD Cahoon ML Hess, et al. 2009 Induction immunosuppression for orthotopic heart transplantation: a review Prog Transplant 19 333 342 20050456
14. RJ Boucek D Naftel MM Boucek, et al. 1999 Induction immunotherapy in pediatric heart transplant recipients: a multicenter study J Heart Lung Transplant 18 460 469 10.1016/S1053-2498(98)00076-X 10363691
15. S Di Fillippo P Boissonnat F Sassolas, et al. 2003 Rabbit antithymocyte globulin as induction immunotherapy in pediatric heart transplantation Transplantation 75 354 358 10.1097/01.TP.0000045223.66828.FA
16. RJ Gajarski ED Blume K Schchtman, et al. 2010 Use of induction agents and incidence of infection and malignancy following pediatric heart transplantation J Heart Lung Transplant 29 2S S70 10.1016/j.healun.2009.11.209
17. SM Pollock-BarZiv T Allain-Rooney C Manlhiot, et al. 2009 Continuous infusion of thymoglobulin for induction therapy in pediatric heart transplant recipients; experience and outcomes with a novel strategy for administration Pediatr Transplant 13 585 589 10.1111/j.1399-3046.2008.01035.x 18992051 1:CAS:528:DC%2BD1MXhtVersrfF
18. F Flaman S Zieroth V Rao, et al. 2006 Basiliximab versus rabbit anti-thymocyte globulin for induction therapy in patients after heart transplantation J Heart Lung Transplant 25 1358 1362 10.1016/j.healun.2006.09. 002 17097501
19. MR Mehra MJ Zucker L Wagoner, et al. 2005 A multicenter, prospective, randomized, double-blind trial of basiliximab in heart transplantation J Heart Lung Transplant 24 1297 1304 10.1016/j.healun.2004.09.010 16143248
20. MF Mattei M Redonnet I Gandjbakhch, et al. 2007 Lower risk of infectious deaths in cardiac transplant patients receiving basiliximab versus anti-thymocyte globulin as induction therapy J Heart Lung Transplant 26 693 699 10.1016/j.healun.2007.05.002 17613399
21. N Grundy J Simmonds H Dawkins, et al. 2009 Pre-implantation basiliximab reduces incidence of early acute rejection in pediatric heart transplantation J Heart Lung Transplant 28 1279 1284 10.1016/j.healun.2009.09.001 19864164 Basiliximab appears to be a safe and effective induction agent when given prior to graft implantation in children undergoing heart transplantation.
22. J Kobashigawa D Morris A Chu, et al. 2005 Daclizumab is associated with decreased rejection and no increased mortality in cardiac transplant patients receiving MMF, cyclosporine and corticosteroids Transplant Proc 37 1333 1339 10.1016/j.transproceed.2004.12.135 15848713 1:CAS:528:DC%2BD2MXjsFKit7o%3D
23. HJ Eisen J Kobashigawa A Keogh, et al. 2005 Three-year results of a randomized double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients J Heart Lung Transplant 24 517 525 10.1016/j.healun.2005.02.002 15896747
24. H Leonard T Hornung G Parry, et al. 2003 Pediatric cardiac transplant: results using a steroid-free maintenance regimen Pediatr Transplant 7 59 63 10.1034/j.1399-3046.2003.00014.x 12581330 1:STN:280:DC%2BD3s%2Fnt1WksQ%3D%3D
25. DA Fullerton DN Campbell SD Jones, et al. 1995 Heart transplantation in children and young adults: early and intermediate-term results Ann Thorac Surg 59 804 811 10.1016/0003-4975(95)00006-7 7695401 1:STN:280:DyaK2M3gvFCntw%3D%3D
26. RR Smith J Wray A Khaghani, et al. 2005 Ten year survival after paediatric heart transplantation: a single centre experience Eur J Cardiothorac Surg 27 790 794 10.1016/j.ejcts.2004.12.058 15848315
27. SP Hmiel C Canter R Shepherd, et al. 2007 Limitations of cyclosporine C2 monitoring in pediatric heart transplant recipients Pediatr Transplant 11 524 529 10.1111/j.1399-3046.2007.00712.x 17631021 1:CAS:528:DC%2BD2sXpt1amsbk%3D
28. G Filler V Rocha de Barros JE Jagger U Christians 2006 Cyclosporin twice or three times daily dosing in pediatric transplant patients-It is not the same! Pediatr Transplant 10 953 956 10.1111/j.1399-3046.2006.00592.x 17096765 1:CAS:528:DC%2BD2sXhtVWqtw%3D%3D
29. SA Webber 2003 The current state of, and future prospects for, cardiac transplantation in children Cardiol Young 13 64 83 10.1017/S104795110300012X 12691291
30. DM Girnita SA Webber R Ferrell, et al. 2006 Disparate distribution of 16 candidate single nucleotide polymorphisms among racial and ethnic groups in pediatric heart transplant patients Transplantation 82 1774 1780 10.1097/01.tp.0000250656.33731.08 17198275 1:CAS:528:DC%2BD2sXjtVKk
31. HX Zheng SA Webber A Zeevi, et al. 2004 The impact of pharmacogenomic factors on steroid weaning in pediatric heart transplant patients using logistic regression analysis Pediatr Transplant 8 551 557 10.1111/j.1399-3046.2004. 00223.x 15598322 1:CAS:528:DC%2BD2MXhtFWrsr4%3D
32. Temple-Smolkin R, Burckart GJ, Zeevi A: Gene polymorphisms and pharmacogenomics. In Pediatric solid organ transplantation, edn 2nd. By Fine RN, Webber SA, Olthoff KM, et al. Malden: Blackwell Publishing; 2007.
33. SR Knight PJ Morris 2008 Does the evidence support the use of mycophenolate mofetil therapeutic drug monitoring in clinical practice? A systematic review Transplantation 85 1675 1685 10.1097/TP.0b013e3181744199 18580456 1:CAS:528:DC%2BD1cXns1Ogt7s%3D
34. EL Ohmann GJ Burckart MM Brooks, et al. 2010 Genetic polymorphisms influence mycophenolate mofetil-related adverse events in pediatric heart transplant patients J Heart Lung Transplant 29 509 516 10.1016/j.healun.2009.11. 602 20061166 This pilot study demonstrates that genetic variations in the target enzymes and drug transporters of MMF have an impact on MMF-related adverse events.
35. P Massari V Duro-Garcia F Giron, et al. 2005 Safety assessment of the conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in stable renal transplant recipients Transplant Proc 37 916 919 10.1016/j.transproceed.2004.12.020 15848574 1:CAS:528:DC%2BD2MXjsFKisrg%3D
36. T Yi L Cuchara Y Wang, et al. 2006 Human allograft arterial injury is ameliorated by sirolimus and ciclosporine and correlates with suppression of interferon-gamma Transplantation 81 559 566 10.1097/01.tp.0000198737.12507.19 16495804 1:CAS:528:DC%2BD28XhslWgtb8%3D
37. E Raichlin JH Bae Z Khalpey, et al. 2007 Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation Circulation 116 2726 2733 10.1161/CIRCULATIONAHA. 107.692996 18025531 1:CAS:528:DC%2BD2sXhtlGns7nP
38. IC Balfour SW Scrun EG Wood, et al. 2006 Early renal benefit of rapamycin combined with reduced calcineurin inhibitor dose in pediatric heart transplantation patients J Heart Lung Transplant 25 518 522 10.1016/j.healun. 2006.01.004 16678029
39. RE Chinnock MF Baum R Larsen, et al. 1993 Rejection management and long-term surveillance of the pediatric heart transplant recipient: the Loma Linda experience J Heart Lung Transplant 12 suppl S255 S264 8312345 1:STN:280:DyaK2c7ks1Srtw%3D%3D
40. BF Feingold P Olesnevich A Zeevi, et al. 2007 Survival in allosensitized children after listing for cardiac transplantation J Heart Lung Transplant 26 565 571 10.1016/j.healun.2007.03.015 17543778
41. SM Pollock-BarZiv N den Hollander BY Ngan, et al. 2007 Pediatric heart transplantation in human leukocyte antigen sensitized patients: evolving management and assessment of intermediate-term outcomes in a high-risk population Circulation 116 11 Suppl I172 I178 17846300
42. DB Holt DM Lublin DL Phelan, et al. 2007 Mortality and morbidity in pre-sensitized pediatric heart transplant recipients with a positive donor crossmatch utilizing peri-operative plasmapheresis and cytolytic therapy J Heart Lung Transplant 26 876 882 10.1016/j.healun.2007.07.011 17845925
43. Z Kaposztas H Podder S Mauiyyedi, et al. 2009 Impact of rituximab therapy for treatment of acute humoral rejection Clin Transplant 23 63 73 10.1111/j.1399-0012.2008.00902.x 19200217 1:STN:280:DC%2BD1M7is12qtg%3D%3D
44. JJ Everly RC Walsh RR Alloway ES Woodle 2009 Proteasome inhibition for antibody-mediated rejection Curr Opin Organ Transplant 14 662 666 10.1097/MOT.0b013e328330f304 19667989
45. WR Morrow E Frazier W Mahle, et al. 2010 Proteasome inhibitor-based therapy for antibody mediated rejection in pediatric heart transplantation Am J Transplant 10 Supp 4 93
46. JK Kirklin JF George DC McGriffin, et al. 1993 Total lymphoid irradiation: is there a role in pediatric heart transplantation? J Heart Lung Transplant 12 S293 S300 8312348 1:STN:280:DyaK2c7ks1Sruw%3D%3D
47. JK Kirklin RN Brown ST Huang, et al. 2006 Rejection with hemodynamic compromise: objective evidence for efficacy of photopheresis J Heart Lung Transplant 25 283 288 10.1016/j.healun.2005.10.004 16507420 1:STN:280: DC%2BD287itFSqsw%3D%3D
48. R Russell-Jones 2001 Shedding light on photopheresis Lancet 357 820 10.1016/S0140-6736(00)04191-X 11265946 1:STN:280:DC%2BD3M7msFygtw%3D%3D
49. JF George CW Gooden L Guo JK Kirklin 2008 Role for CD4(+)CD25(+) T cells in inhibition of graft rejection by photopheresis J Heart Lung Transplant 27 616 622 10.1016/j.healun.2008.02.015 18503960